Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2021 Filed Feb 22, 2021 20:45 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
GrantCommon Stock | 6,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013006 · doc4.xml · nonDerivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,575 F1 · kind: On January 31, 2018, the reporting person was granted 3,740 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:45 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Tax withholdingCommon Stock | 5,583 | $174.61 | $974,847.63 |
DisclosureSEC source: 0001209191-21-013004 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,677.7241 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:45 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GrantCommon Stock | 14,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013004 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,260.7241 F1 · kind: On January 31, 2018, the reporting person was granted 8,710 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:42 UTC |
Paslick P. MartinSVP and CIO
|
Tax withholdingCommon Stock | 4,788 | $174.61 | $836,032.68 |
DisclosureSEC source: 0001209191-21-013001 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,878 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:42 UTC |
Paslick P. MartinSVP and CIO
|
GrantCommon Stock | 12,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013001 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,666 F1 · kind: On January 31, 2018, the reporting person was granted 7,470 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:42 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
Tax withholdingCommon Stock | 1,567 | $174.61 | $273,613.87 |
DisclosureSEC source: 0001209191-21-013000 · doc4.xml · nonDerivative · entry 2 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578.2729 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:42 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GrantCommon Stock | 6,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013000 · doc4.xml · nonDerivative · entry 1 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,145.2729 F1 · kind: On January 31, 2018, the reporting person was granted 3,740 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:41 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Tax withholdingCommon Stock | 1,567 | $174.61 | $273,613.87 |
DisclosureSEC source: 0001209191-21-012998 · doc4.xml · nonDerivative · entry 2 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,121.8654 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:41 UTC |
Morgan Sandra L.SVP-Provider Relations
|
GrantCommon Stock | 6,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012998 · doc4.xml · nonDerivative · entry 1 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,688.8654 F1 · kind: On January 31, 2018, the reporting person was granted 3,740 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:40 UTC |
HAZEN SAMUEL NDirector · CEO
|
GrantRestricted Stock Units · Derivative | 6,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012996 · doc4.xml · derivative · entry 4 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,011 Underlying: Common Stock · 6,011 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of HCA Healthcare, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest on the first anniversary of the grant date. F3 · derivative.expiration_date: The restricted stock units vest on the first anniversary of the grant date. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:40 UTC |
HAZEN SAMUEL NDirector · CEO
|
Tax withholdingCommon Stock | 18,282 | $174.61 | $3,192,220.02 |
DisclosureSEC source: 0001209191-21-012996 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,829 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:40 UTC |
HAZEN SAMUEL NDirector · CEO
|
GrantCommon Stock | 48,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012996 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,111 F1 · kind: On January 31, 2018, the reporting person was granted 29,860 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:41 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Tax withholdingCommon Stock | 5,583 | $174.61 | $974,847.63 |
DisclosureSEC source: 0001209191-21-012997 · doc4.xml · nonDerivative · entry 2 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,381 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:41 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GrantCommon Stock | 14,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012997 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,964 F1 · kind: On January 31, 2018, the reporting person was granted 8,710 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:40 UTC |
Hall Charles JGroup President
|
Tax withholdingCommon Stock | 6,384 | $174.61 | $1,114,710.24 |
DisclosureSEC source: 0001209191-21-012995 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,876 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:40 UTC |
Hall Charles JGroup President
|
GrantCommon Stock | 16,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012995 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,260 F1 · kind: On January 31, 2018, the reporting person was granted 9,960 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:39 UTC |
Foster Jon MGroup President
|
Tax withholdingCommon Stock | 6,384 | $174.61 | $1,114,710.24 |
DisclosureSEC source: 0001209191-21-012994 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,838 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:39 UTC |
Foster Jon MGroup President
|
GrantCommon Stock | 16,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012994 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,222 F1 · kind: On January 31, 2018, the reporting person was granted 9,960 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:39 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Tax withholdingCommon Stock | 2,360 | $174.61 | $412,079.60 |
DisclosureSEC source: 0001209191-21-012993 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,260 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:39 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
GrantCommon Stock | 8,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012993 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,620 F1 · kind: On January 31, 2018, the reporting person was granted 4,980 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:38 UTC |
Billington Phillip GSVP-Internal Audit Services
|
Tax withholdingCommon Stock | 3,164 | $174.61 | $552,466.04 |
DisclosureSEC source: 0001209191-21-012991 · doc4.xml · nonDerivative · entry 3 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,973.98 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:38 UTC |
Billington Phillip GSVP-Internal Audit Services
|
GrantCommon Stock | 6,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012991 · doc4.xml · nonDerivative · entry 2 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,137.98 F2 · kind: On October 31, 2018, the reporting person was granted 3,740 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:38 UTC |
Billington Phillip GSVP-Internal Audit Services
|
GrantCommon Stock | 4,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012991 · doc4.xml · nonDerivative · entry 1 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,046.98 F1 · kind: On January 31, 2018, the reporting person was granted 2,490 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:38 UTC |
Cuffe Michael S.President-Physician Services
|
Tax withholdingCommon Stock | 5,583 | $174.61 | $974,847.63 |
DisclosureSEC source: 0001209191-21-012992 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,860.2452 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:38 UTC |
Cuffe Michael S.President-Physician Services
|
GrantCommon Stock | 14,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012992 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,443.2542 F1 · kind: On January 31, 2018, the reporting person was granted 8,710 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:37 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Tax withholdingCommon Stock | 1,301 | $174.61 | $227,167.61 |
DisclosureSEC source: 0001209191-21-012990 · doc4.xml · nonDerivative · entry 2 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,072 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:37 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
GrantCommon Stock | 3,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012990 · doc4.xml · nonDerivative · entry 1 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,373 F1 · kind: On January 31, 2018, the reporting person was granted 2,030 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 19:23 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 6,000 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-21-012153 · doc4.xml · derivative · entry 6 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 19:23 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 3,825 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-012153 · doc4.xml · derivative · entry 5 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,825 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 19:23 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 4,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-012153 · doc4.xml · derivative · entry 4 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 19:23 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Tax withholdingCommon Stock | 7,633 | $174.00 | $1,328,142.00 |
DisclosureSEC source: 0001209191-21-012153 · doc4.xml · nonDerivative · entry 3 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,067 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 19:23 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Exercise / conversionCommon Stock | 6,000 | $68.96 | $413,760.00 |
DisclosureSEC source: 0001209191-21-012153 · doc4.xml · nonDerivative · entry 2 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 19:23 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Exercise / conversionCommon Stock | 8,325 | $47.97 | $399,350.25 |
DisclosureSEC source: 0001209191-21-012153 · doc4.xml · nonDerivative · entry 1 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2021 Filed Jul 29, 2021 18:33 UTC |
Hall Charles JGroup President
|
GiftCommon Stock | 5,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048654 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,140 Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 19:15 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionStock Appreciation Right · Derivative | 8,000 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-21-009448 · doc4.xml · derivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 19:15 UTC |
Wyatt Christopher F.SVP & Controller
|
Tax withholdingCommon Stock | 4,308 | $178.94 | $770,873.52 |
DisclosureSEC source: 0001209191-21-009448 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,629 Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 19:15 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionCommon Stock | 8,000 | $68.96 | $551,680.00 |
DisclosureSEC source: 0001209191-21-009448 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 19:14 UTC |
Foster Jon MGroup President
|
SaleCommon Stock | 6,171 | $176.44 | $1,088,811.24 |
DisclosureSEC source: 0001209191-21-009447 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 05, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 62,936 | $177.38 | $11,163,342.23 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · nonDerivative · entry 5 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,099 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.00 to $177.59, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 05, 2021 Filed Feb 5, 2021 20:27 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
SaleCommon Stock | 10,000 | $179.93 | $1,799,300.00 |
DisclosureSEC source: 0001209191-21-008346 · doc4.xml · nonDerivative · entry 3 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,778 Read SEC document |
| February 05, 2021 Filed Feb 5, 2021 20:25 UTC |
Cuffe Michael S.President-Physician Services
|
SaleCommon Stock | 13,718 | $176.22 | $2,417,442.20 |
DisclosureSEC source: 0001209191-21-008341 · doc4.xml · nonDerivative · entry 5 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,257.2542 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.00 to $176.79, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes 2,072.2542 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:33 UTC |
Riley Wayne JosephDirector
|
SaleCommon Stock | 1,650 | $175.00 | $288,750.00 |
DisclosureSEC source: 0001209191-21-008359 · doc4.xml · nonDerivative · entry 2 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,469 F1 · kind: The sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:32 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 1,400 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · derivative · entry 6 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Underlying: Common Stock · 1,400 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:32 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Tax withholdingCommon Stock | 653 | $179.30 | $117,082.90 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · nonDerivative · entry 4 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,016 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:32 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionCommon Stock | 1,400 | $47.97 | $67,158.00 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · nonDerivative · entry 3 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:32 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
GiftCommon Stock | 415 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,269 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:32 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
SaleCommon Stock | 280 | $177.11 | $49,590.80 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,684 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 9,150 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · derivative · entry 14 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,575 Underlying: Common Stock · 9,150 shares Expires 2028-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Tax withholdingCommon Stock | 6,733 | $179.30 | $1,207,226.90 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · nonDerivative · entry 9 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,397 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 9,150 | $101.16 | $925,614.00 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · nonDerivative · entry 8 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.